TipRanks
Gilead Sciences (GILD)
NASDAQ:GILD
US Market
GILD
Gilead Sciences
RESEARCH TOOLSreports
Want to see GILD full AI Analyst Report?

Gilead Sciences (GILD) Stock News & Sentiment

14,000 Followers
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
Premium
TipRanks Newswire
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
4d ago
LLY
AMGN
Michael Yee Reiterates Buy on Gilead, Highlighting Yeztugo-Driven HIV Growth and Maintaining Unchanged $175 Price Target
Premium
Ratings
Michael Yee Reiterates Buy on Gilead, Highlighting Yeztugo-Driven HIV Growth and Maintaining Unchanged $175 Price Target
16d ago
GILD
3 Best ETFs Offering 10%+ Upside, Picked by AI Analyst
Premium
Market News
3 Best ETFs Offering 10%+ Upside, Picked by AI Analyst
20d ago
VZ
BMY
Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst
Premium
Company Announcements
Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst
1M ago
GILD
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
Premium
Market News
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
1M ago
GILD
Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why
Premium
Market News
Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why
2M ago
MRK
TEM
Gilead Sciences Earnings Call Highlights Strong Core Growth
Premium
Company Announcements
Gilead Sciences Earnings Call Highlights Strong Core Growth
2M ago
GILD
More GILD News >

GILD News on the Web

Gilead Has Outperformed the S&P 500. But is its Valuation Still Attractive?
Insider Monkey
Neutral
Bank of America is bullish on these top stocks ahead of earnings
CNBC
Neutral
For the final 10% of cystic fibrosis, the breakthrough still hasn't come
CNBC
Neutral
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
Zacks
Neutral
Gilead Sciences (GILD) Chairman & CEO Daniel O'day Sells 15,000 Shares
GuruFocus News
Neutral
Gilead put volume heavy and directionally bearish
TipRanks News
Neutral
Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification?
Insider Monkey
Neutral
Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own?
Insider Monkey
Bullish

News Score - Last 7 Days

Very Positive
GILD
Sector Average
Media Buzz
This Week24 articles
Weekly Average14.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GILD’s Media Buzz Sentiment?
24 articles about GILD were published this week. In an average week, 14.25 articles are published.
    What is GILD’s weekly average amount of articles?
    In an average week, 14.25 articles about GILD are published.
      What is GILD’s News Sentiment?
      100% of articles about GILD were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AMGNAmgen
        GKOSGlaukos
        OVIDOvid Therapeutics
        ABTAbbott Laboratories
        IQVIQVIA Holdings
        Showing the stocks with the most bullish news sentiment over the past week